Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Lilly Oncology chief resigns

January 27, 2011 Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing

Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
News

Novartis posts strong growth but warns of tough year ahead

January 27, 2011 Sales and Marketing 2010 pharma results, Novartis

Novartis has posted strong sales growth for the full year but its chief executive warns of ‘headwinds in 2011’ as …
News

Prime Minister uses online network to rally doctors around reforms

January 27, 2011 Sales and Marketing Doctors.net.uk, GPs, commissioning, david cameron, docotrs, prime minister

 Prime Minister David Cameron has made exclusive use of Doctors.net.uk, the UK’s largest network of medical professionals, to reinforce his …
News
Press release

NICE decides to back Abilify in schizophrenia

January 27, 2011 Sales and Marketing Abilify, BMS, Bristol-Myers Squibb, NICE, Otsuka, aripiprazole, schizophrenia

NICE has changed its mind over Bristol-Myers Squibb’s and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia …
News

Double Helix Consulting expands

January 26, 2011 Sales and Marketing Clara Loveman, Double Helix, Dr Clive Whitcher, Dr Laurence Wild, appointment, sales and marketing

Double Helix Consulting has appointed three new executives to its growing global team – Clara Loveman, Dr Clive Whitcher and …
Appointment

J&J posts negative growth as pharma sales stall

January 26, 2011 Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta

Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …
News

Eisai sepsis drug fails in phase III

January 26, 2011 Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis

A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …
News

Novartis MS drug steals march over Merck rival

January 24, 2011 Sales and Marketing Cladribine, MS, Merck KGaA, Novartis, fingolimod, gilenya, multiple sclerosis

Novartis’ oral multiple sclerosis Gilenya could be on the European market in just three months after winning the backing of …
News

Novartis offers $470m to boost personalised cancer treatment

January 24, 2011 Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine

Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …
News

ABPI warns of postcode prescribing

January 21, 2011 Sales and Marketing ABPI, Cancer Drugs Fund, NICE, cancer drug prescribing, postcode prescribing

The ABPI has said the government’s forthcoming Cancer Drugs Fund could increase the problems of postcode prescribing. The UK industry …
News

Health Bill continues fast pace of NHS reform

January 20, 2011 Sales and Marketing GP consortia, NHS, NHS Commissioning Board, NHS reforms, NICE, QALY

The government has outlined its draft Health and Social Care Bill, making some minor concessions to critics but promising no …
News

Caution raised on statins in healthy people

January 20, 2011 Sales and Marketing Cochrane, Crestor, Lipitor, statin, statin prescribing

Researchers have warned of a lack of evidence to support prescribing statins in patients at low risk of developing heart …
News

Key drug launches for 2011

January 20, 2011 Sales and Marketing Benlysta, Cladribine, Movectro, Pradaxa, Xarelto, axitinib, boceprevir, crizotinib, telaprevir

This year is expected to see new treatments for hepatitis C, multiple sclerosis and lupus among those that could reach …
Feature

Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG

January 19, 2011 Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing

The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …
News

EMA’s Thomas Lönngren joins market access firm

January 19, 2011 Research and Development, Sales and Marketing NDA Group, Thomas Lönngren, appointment, recruitment, research and development, sales and marketing

The former head of the EMA Thomas Lönngren has taken up a post at new European regulatory and market access …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026